Imcheck is listed on the portfolio pages of Andera Partners (portfolio page) and Eurazeo (portfolio page). Andera Partners and Eurazeo list it as current. Andera Partners has owned Imcheck since 2022, per Andera Partners' portfolio page. Eurazeo has owned Imcheck since 2019, per Eurazeo's portfolio page.
Imcheck is a Healthcare company. Its owner on record, Andera Partners, is a private equity firm. Andera Partners lists 291 companies in the index, 36 of them in Healthcare. Also backed by Eurazeo.
Andera Partners is a private equity asset management firm that invests in companies and their management to support growth and innovation.
Read the Andera Partners profileEurazeo is a leading French private equity firm and investment group that manages a diversified portfolio of over 600 companies.
Read the Eurazeo profileImcheck is listed on the portfolio pages of Andera Partners (portfolio page) and Eurazeo (portfolio page). Andera Partners and Eurazeo list it as current. Andera Partners has owned Imcheck since 2022, per Andera Partners' portfolio page. Eurazeo has owned Imcheck since 2019, per Eurazeo's portfolio page.
Imcheck is in Healthcare. Classified from the owner's portfolio label.
Andera Partners lists 35 other Healthcare companies in the index, including Adler Ortho, AgoMab, AM Pharma, Amolyt Pharma and Artios Pharma.
6 of 290 shown
See the full Andera Partners portfolio.
6 of 265 shown
See the full Eurazeo portfolio.
Browse PE-backed companies.
